By Scott Flaherty ( March 30, 2012, 2:01 PM EDT) -- A New Jersey federal judge on Thursday found that four generics makers infringed an AstraZeneca PLC patent on the anti-psychotic Seroquel XR, effectively clearing the path for AstraZeneca to sell the blockbuster drug without generic competition for the next five years....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.